Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-24-000083

EVP Strategy and Corporate Dev sold 2,423 shares at $126.58 ($306,703)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dolan Matthew Vincent EVP Strategy and Corporate Dev 2024-05-15 Sale 10b5-1 −2,423 $126.58 $306,703 40,075 D: show line 1 in the form
Open-market sales · 2,423 sh · avg $126.58 · $306,703
Loading xslF345X05/edgardoc.xml…